Long-term outcomes of locally or radically resected T1 colorectal cancer

2016 ◽  
Vol 18 (9) ◽  
pp. 852-860 ◽  
Author(s):  
M. J. Nam ◽  
K. S. Han ◽  
B. C. Kim ◽  
C. W. Hong ◽  
D. K. Sohn ◽  
...  
2021 ◽  
Vol 93 (6) ◽  
pp. AB86
Author(s):  
Hirohito Tanaka ◽  
Shiko Kuribayashi ◽  
Masanori Sekiguchi ◽  
Atsuo Iwamoto ◽  
Yoko Hachisu ◽  
...  

2020 ◽  
Vol 18 (12) ◽  
pp. 2813-2823.e5 ◽  
Author(s):  
Jen-Hao Yeh ◽  
Cheng-Hao Tseng ◽  
Ru-Yi Huang ◽  
Chih-Wen Lin ◽  
Ching-Tai Lee ◽  
...  

2020 ◽  
Vol 9 (8) ◽  
pp. 2451
Author(s):  
Eun Young Park ◽  
Dong Hoon Baek ◽  
Moon Won Lee ◽  
Gwang Ha Kim ◽  
Do Youn Park ◽  
...  

Background and Aims: Endoscopic resection (ER) for submucosal invasive colorectal cancer (T1 CRC) can be grouped as curative ER (C-ER) and non-curative ER (NC-ER). Little is known about the long-term outcomes of patients in these two groups. Therefore, we have evaluated the long-term outcomes in endoscopically resected T1 CRC patients in C-ER and NC-ER groups. Methods: We conducted a retrospective study on 220 patients with T1 CRC treated with ER from January 2007 to December 2017. First, we investigated the long-term outcomes (5-year overall survival [OS] and recurrence-free survival [RFS]) in the C-ER group (n = 49). In the NC-ER group (n = 171), we compared long-term outcomes between patients who underwent additional surgical resection (ASR) (n = 117) and those who did not (surveillance-only, n = 54). Results: T1 CRC patients in the C-ER and NC-ER groups had a median follow-up of 44 (interquartile range 32–69) months. There was no risk of tumor recurrence and cancer-related deaths in patients with C-ER. In the NC-ER group, the 5-year OS rates were 75.3% and 92.6% in the surveillance-only and ASR subgroups, respectively. The hazard ratio (HR) for ASR in NC-ER vs. surveillance-only in NC-ER was statistically insignificant. However, RFS rates were significantly different between the ASR (97.2%) and surveillance-only (84.0%) subgroups. Multivariate analysis indicated a submucosal invasion depth (SID) of >2500 µm and margin positivity to be associated with recurrence. Conclusions: The surveillance-only approach can be considered as an alternative surgical option for T1 CRCs in selected patients undergoing NC-ER.


2020 ◽  
Vol 91 (6) ◽  
pp. AB447
Author(s):  
Jen-Hao Yeh ◽  
Chih-Wen Lin ◽  
Cheng-Hao Tseng ◽  
Ching-Tai Lee ◽  
Tsung-Chin Wu ◽  
...  

PLoS ONE ◽  
2019 ◽  
Vol 14 (8) ◽  
pp. e0220579 ◽  
Author(s):  
Hironori Mizuno ◽  
Norihiro Yuasa ◽  
Eiji Takeuchi ◽  
Hideo Miyake ◽  
Hidemasa Nagai ◽  
...  

2018 ◽  
Vol 154 (6) ◽  
pp. S-1352
Author(s):  
Riku Yamamoto ◽  
Shinya Munakata ◽  
Tomoyuki Kushida ◽  
Hajime Orita ◽  
Mutsumi Sakurada ◽  
...  

2020 ◽  
Author(s):  
Yun Xu ◽  
Cong Li ◽  
Charlie Zhi-Lin Zheng ◽  
Yu-Qin Zhang ◽  
Tian-An Guo ◽  
...  

Abstract Background Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome. Comparison of prognosis between LS and sporadic CRC (SCRC) were rare,with conflicting results. This study aimed to compare the long-term outcomes between patients with LS and SCRC. Methods Between June 2008 and September 2018, a total of 47 patients were diagnosed with LS by genetic testing at Fudan University Shanghai Cancer Center. A 1:2 propensity score matching was performed to obtain homogeneous cohorts from SCRC group. Thereafter, 94 SCRC patients were enrolled as control group. The long-term survival rates between the two groups were compared, and the prognostic factors were also analyzed. Results The 5-year OS rate of LS group was 97.6%, which was significantly higher than of 82.6% for SCRC group (p = 0.029). The 5-year PFS rate showed no significant differences between the two groups (78.0% for LS group vs. 70.6% for SCRC patients; p = 0.262). The 5-year TFS rates in LS group was 62.1% for LS patients, which were significantly lower than of 70.6% for SCRC group (p = 0.039). By multivariate analysis, we found that tumor progression of primary CRC and TNM staging were independent risk factors for OS. Conclusion LS patients have better long-term survival prognosis than SCRC patients. Strict regular follow-up monitoring, detection at earlier tumor stages, and effective treatment are key to ensuring better long-term prognosis.


Sign in / Sign up

Export Citation Format

Share Document